Roche Appeals Accutane Label Ruling To NJ High Court

By Jeannie O'Sullivan (August 24, 2017, 5:44 PM EDT) -- Hoffman-La Roche Inc. and Roche Laboratories Inc. on Thursday asked the New Jersey Supreme Court to review an appellate court's ruling that the label of its acne drug Accutane didn't adequately warn users of possible gastrointestinal side effects, arguing that the decision undermines the presumptive power of FDA-approved labels....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as